Literature DB >> 18045737

Core temperature cooling in healthy volunteers after rapid intravenous infusion of cold and room temperature saline solution.

Tracy M Moore1, Clifton W Callaway, David Hostler.   

Abstract

STUDY
OBJECTIVE: Studies have suggested that inducing mild hypothermia improves neurologic outcomes after traumatic brain injury, major stroke, traumatic hemorrhage, and cardiac arrest. Although infusion of cold normal saline solution is a simple and inexpensive method for initiating hypothermia, human cold-defense mechanisms potentially make this route stressful or ineffective. We hypothesize that rapid infusion of 30 mL/kg of cold (4 degrees C, 39.2 degrees F) 0.9% saline solution during 30 minutes to healthy subjects (aged 27 [standard deviation (SD) 4] years) will reduce core body temperature to the therapeutic range of 33 degrees C to 35 degrees C (91.4 degrees F to 95 degrees F).
METHODS: Sixteen subjects were randomly assigned to receive either cold (4 degrees C, 39.2 degrees F) or room temperature (23 degrees C, 73.4 degrees F) normal saline solution. Subjects were not informed of their assignment, but blinding was not possible after initiation of the infusion. Core temperature, skin temperature, and vital signs were recorded every 2 minutes. Subjects indicated global discomfort during the infusion on a 100-mm visual analog scale at 5-minute intervals.
RESULTS: Core temperature decreased in both the cold saline solution (1.0 degrees C [SD 0.4 degrees C]/1.8 degrees F [0.7 degrees F]) and room temperature saline solution (0.5 degrees C [SD 0.1 degrees C]/0.9 degrees F [0.2 degrees F]) groups, whereas skin temperature was unchanged. Slopes calculated from the core temperature cooling curves indicate that the majority of cooling occurred during the first half of the infusion. Examination of the core temperature cooling curves revealed a 2-phase temporal pattern in 30-minute cooling curves. The early phase, spanning 0 to 14 minutes, demonstrated rapid cooling in both groups, with a larger effect observed in subjects receiving cold saline solution.
CONCLUSION: In this pilot study of healthy volunteers, rapid administration of cold saline solution to awake normothermic volunteers resulted in 1 degrees C (1.8 degrees F) cooling but did not induce a therapeutic plane of hypothermia. This change in core temperature was not accompanied by significant changes in skin temperature. These data suggest that a reduction in core temperature of about 1 degrees C (1.8 degrees F) can be achieved in healthy humans before a thermoregulatory response is triggered and that rapid infusion of cold intravenous fluids is insufficient by itself to overcome this response. The clinically relevant control arm of room temperature saline solution also resulted in mild core cooling.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18045737     DOI: 10.1016/j.annemergmed.2007.07.012

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  13 in total

1.  Cooling to Facilitate Metabolic Suppression in Healthy Individuals.

Authors:  Jon C Rittenberger; Kathryn L Flickinger; Alexandra Weissman; Melissa Repine; Jonathan Elmer; Francis X Guyette; Clifton W Callaway
Journal:  Aerosp Med Hum Perform       Date:  2019-05-01       Impact factor: 1.053

2.  Comparison of active cooling devices with passive cooling for rehabilitation of firefighters performing exercise in thermal protective clothing: a report from the Fireground Rehab Evaluation (FIRE) trial.

Authors:  David Hostler; Steven E Reis; James C Bednez; Sarah Kerin; Joe Suyama
Journal:  Prehosp Emerg Care       Date:  2010 Jul-Sep       Impact factor: 3.077

Review 3.  Amnioinfusion for chorioamnionitis.

Authors:  G Justus Hofmeyr; Joseph A K Kiiza
Journal:  Cochrane Database Syst Rev       Date:  2016-08-24

4.  Induction of a prolonged hypothermic state by drug-induced reduction in the thermoregulatory set-point.

Authors:  Laurence M Katz; Jonathan E Frank; Gerald McGwin; Alex Finch; Christopher J Gordon
Journal:  Ther Hypothermia Temp Manag       Date:  2012-06       Impact factor: 1.286

5.  Mild hypothermia alters midazolam pharmacokinetics in normal healthy volunteers.

Authors:  David Hostler; Jiangquan Zhou; Michael A Tortorici; Robert R Bies; Jon C Rittenberger; Philip E Empey; Patrick M Kochanek; Clifton W Callaway; Samuel M Poloyac
Journal:  Drug Metab Dispos       Date:  2010-02-17       Impact factor: 3.922

6.  Surface cooling for induction of mild hypothermia in conscious healthy volunteers - a feasibility trial.

Authors:  Christoph Testori; Fritz Sterz; Wilhelm Behringer; Alexander Spiel; Christa Firbas; Bernd Jilma
Journal:  Crit Care       Date:  2011-10-22       Impact factor: 9.097

7.  Glycopyrrolate does not ameliorate hypothermia associated bradycardia in healthy individuals: A randomized crossover trial.

Authors:  Jon C Rittenberger; Alexandra Weissman; Katharyn L Flickinger; Francis X Guyette; David Hopkins; Melissa J Repine; Cameron Dezfulian; Ankur A Doshi; Jonathan Elmer; Kelly N Sawyer; Clifton W Callaway
Journal:  Resuscitation       Date:  2021-06-01       Impact factor: 6.251

8.  Dexmedetomidine Reduces Shivering during Mild Hypothermia in Waking Subjects.

Authors:  Clifton W Callaway; Jonathan Elmer; Francis X Guyette; Bradley J Molyneaux; Kacey B Anderson; Philip E Empey; Stacy J Gerstel; Kate Holquist; Melissa J Repine; Jon C Rittenberger
Journal:  PLoS One       Date:  2015-08-03       Impact factor: 3.240

Review 9.  Induction of therapeutic hypothermia by pharmacological modulation of temperature-sensitive TRP channels: theoretical framework and practical considerations.

Authors:  Viktor V Feketa; Sean P Marrelli
Journal:  Temperature (Austin)       Date:  2015-04-27

Review 10.  Contemporary Management of Out-of-hospital Cardiac Arrest in the Cardiac Catheterisation Laboratory: Current Status and Future Directions.

Authors:  Nilesh Pareek; Peter Kordis; Ian Webb; Marko Noc; Philip MacCarthy; Jonathan Byrne
Journal:  Interv Cardiol       Date:  2019-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.